Neptune Investment Management
VC Fund
City Of London, United Kingdom
Neptune Investment Management is a VC fund in City Of London focused on Gaming and Medical. Neptune is a UK-based fund management company offering a range of ISA-friendly equity funds to private investors, advisers and institutional clients.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Neptune Investment Management invests in
Stages Neptune Investment Management invests in
Countries Neptune Investment Management invests in
Round sizes
Round size
- Series A
- $13M–$28M
Investment Focus
Industry
- Gaming 2 (50%)
- Medical 2 (50%)
- Social 1 (25%)
- Software 1 (25%)
- Health Care 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Series B 1 (25%)
Country
- South Korea 2 (50%)
- United Kingdom 2 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HAEGIN
|
HAEGIN is a game development company. | $83.5M / Series B / Feb 27, 2022 | |
Ultromics
|
Ultromics develops AI-powered software solutions to assist in cardiovascular disease diagnosis through echocardiography. The company provides platforms that support clinicians in interpreting echocardiogram data by applying machine learning to detect patterns and abnormalities that may indicate heart conditions. Ultromics offers its flagshipproduct, EchoGo, which automates the analysis of echocardiograms and delivers quantitative reports on cardiac function and structure. The software integrates with existing clinical workflows and is designed to enhance decision-making consistency while reducing variability in scan interpretation. Ultromics focuses on leveraging data-driven approaches to support early detection of conditions such as heart failure and coronary artery disease. Its technology is built on research collaborations and large-scale clinical datasets, aiming to improve diagnostic outcomes and support clinical efficiency. | $13.4M / Series A / May 22, 2018 | |
Barinthus Biotherapeutics
|
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company’s proprietary platform comprises proprietary modified simian adenoviral vectors, known as ChAdOx1 and ChAdOx2, aswell as the well-validated Modified Vaccinia Ankara, or MVA, boost vector, both with demonstrable safety profiles and without the ability to replicate in humans. The combination of a ChAdOx prime treatment with subsequent MVA boost has consistently generated significantly higher magnitudes of CD8+ T cells compared with other technologies and approaches. The company has a broad pipeline of both clinical and preclinical stage therapeutic programs in solid tumors and viral infections and prophylactic viral vaccine programs. Vaccitech co-invented a COVID-19 vaccine with the University of Oxford, now approved for use in many territories and exclusively licensed worldwide to AstraZeneca through Oxford University Innovation, or OUI. Vaccitech is entitled to receive a share of the milestones and royalty income received by OUI from AstraZeneca. | $27.6M / Series A / Jan 15, 2018 | |
Bob Games
|
A Social casino game developer. | $3.5M / Seed / Oct 17, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Neptune Investment Management invest in?
Neptune Investment Management invests primarily in Gaming, Medical and Social startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Neptune Investment Management's check size?
Neptune Investment Management typically joins rounds of $13M–$28M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Neptune Investment Management participates in.
When did Neptune Investment Management last invest?
The most recent investment recorded for Neptune Investment Management closed in Feb 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
